Colgate Palmolive (India) Limited has partnered with Kaun Banega Crorepati Season 18 (KBC 18) to launch an initiative aimed at enhancing oral health awareness among Indian families. This collaboration leverages the show’s massive family appeal to turn everyday oral health awareness into actionable habits.

Strategic Collaboration

The partnership between Colgate and KBC 18 aims to create the biggest oral health conversations that can help protect India’s smiles. KBC 18’s core campaign thought, ‘Sochna Padega’, naturally mirrors Colgate’s mission to make Indian families rethink their oral hygiene routines. The integration ensures that the message of nighttime brushing is delivered with the same gravity and trust as the show’s trivia, cementing it as an everyday family ritual.

Impactful Campaign

Right as millions of families wind down for bed, the legendary host Amitabh Bachchan closes each episode in his signature style with a very intentional twist – 100 unique sign-offs through the season declaring the message: ‘Colgate aur KBC dwaara Daant hit mein jaari’ (Issued in dental interest). This initiative is designed to educate viewers on the importance of oral health, turning television viewing into a catalyst for positive habits.

Gunjit Jain, Executive Vice President, Marketing, Colgate-Palmolive (India) Limited, said, “Kaun Banega Crorepati has a unique ability to make knowledge feel personal. By embedding our core message into the show’s daily narrative, we are bringing oral health conversations into a culturally relevant environment and equipping families to make choices that positively impact their lives and smiles.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Colgate Palmolive (India) Limited

Colgate Palmolive (India) Limited belongs to the Consumer Defensive › Household & Personal Products sector. Here’s a quick read on where the business and the stock stand today.

Colgate falls 11.3% over three months and has not found a floor yet. The PEG stands at 4.44 — severely stretched. Any earnings miss could trigger a sharp de-rating. Margins at 21.7% are impressive but need to be sustained — any compression would be a red flag. RSI stands at 29, well into oversold territory. Yet sellers still dominated on 20 of recent sessions versus 10 for buyers, so the pressure has not fully lifted. Revenue grows at 4.9% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Colgate Palmolive (India) Limited.

Colgate Palmolive (India) Limited (COLPAL) announced on August 18, 2026, that its advanced gum care portfolio – comprising PerioGard Toothpaste, Toothbrush, and Mouthwash – has become the first in India to receive the Indian Society of Periodontology (ISP) Seal of Acceptance. This recognition marks a significant milestone in Indian oral healthcare, underscoring the brand’s commitment to advancing solution-oriented care through rigorous, clinical innovation.

Significant Milestone in Oral Healthcare

As awareness of oral health continues to grow, gum health remains an under-prioritized yet critical aspect of overall wellness. Beyond the mouth, clinical research increasingly links poor gum health to broader systemic conditions, including cardiovascular disease, diabetes complications, and adverse pregnancy outcomes. This recognition seeks to bring greater focus to the role of healthy gums in maintaining long-term full-body health, reflecting a shared commitment to promoting proactive education and solution-oriented care across India.

Reinforces Leadership in Evidence-Based Care

The prestigious ISP Seal is awarded only after a stringent scientific evaluation of a product’s safety and efficacy. By earning this distinction, Colgate PerioGard not only reinforces its leadership in evidence-based care but also establishes a new national benchmark for validated gum health solutions. Ms. Prabha Narasimhan, Managing Director, Colgate-Palmolive (India) Limited, said, “We fundamentally believe that healthier gums are the foundation of a healthier mouth, yet the category continues to receive far less attention than it deserves. Earning this independent validation is a proud reflection of our mission to elevate the standard of oral care in India. We hope this milestone sparks a wider national conversation around gum health and empowers people to make informed, proactive choices for their overall well-being.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Colgate Palmolive (India) Limited

Colgate Palmolive (India) Limited belongs to the Consumer Defensive › Household & Personal Products sector. Here’s a quick read on where the business and the stock stand today.

Colgate falls 8.3% over three months and has not found a floor yet. The PEG stands at 4.90 — severely stretched. Any earnings miss could trigger a sharp de-rating. Margins at 21.7% are impressive but need to be sustained — any compression would be a red flag. The stock holds at 28% of its 52-week range with RSI at 38. In other words, neither side has a clear edge right now. Revenue grows at 4.9% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Colgate Palmolive (India) Limited.

Colgate Palmolive (India) Limited (NSE: COLPAL) held its board meeting today, revealing financial results for the quarter ending June 30, 2026. The meeting commenced at 10.30 a.m. (IST) and concluded at 11.30 a.m. (IST). The board reviewed the company’s unaudited financial results for the quarter, which showed a robust performance.

Financial Performance Overview

The company’s revenue from operations for the quarter ended June 30, 2026, stood at Rs. 1,59,056 lakhs, marking a 12.0% increase compared to the same period last year. Other operating income also saw a slight rise, totaling Rs. 1,274 lakhs. Total income for the quarter was Rs. 1,62,610 lakhs. Expenses, including cost of materials consumed and employee benefits, remained consistent with previous quarters.

Profitability

Profit before exceptional items and tax for the quarter was Rs. 46,553 lakhs. An exceptional expense of Rs. 334 lakhs was recorded due to organizational changes. The net profit for the quarter was Rs. 34,308 lakhs, reflecting a strong financial health of the company.

As a result, Colgate Palmolive (India) Limited (NSE: COLPAL) continues to demonstrate solid financial performance for the quarter ending June 30, 2026.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Colgate Palmolive (India) Limited

Colgate Palmolive (India) Limited belongs to the Consumer Defensive › Household & Personal Products sector. Here’s a quick read on where the business and the stock stand today.

Colgate moves sideways over three months, with neither buyers nor sellers taking control. The PEG stands at 5.35 — severely stretched. Any earnings miss could trigger a sharp de-rating. Margins at 22.0% are impressive but need to be sustained — any compression would be a red flag. The stock holds at 49% of its 52-week range with RSI at 62. In other words, neither side has a clear edge right now. The stock rises 0.3% in three months on 4.9% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Colgate Palmolive (India) Limited.